blood fractions News
-
Tales from TCT 2019: Ancora’s Heart Felt Data
During the 31st annual Transcatheter Cardiovascular Therapeutics scientific symposium, Santa Clara, CA-based Ancora presented interim study results from systolic heart failure patients treated with AccuCinch, a percutaneous therapy designed to improve left ventricular function. A stronger and more experienced Ancora Heart entered into the 31st Transcatheter Cardiovascular Therapeutics (TCT), ...
-
Dupixent (dupilumab) Approved by European Commission for Children Aged 6 to 11 Years with Severe Asthma with Type 2 Inflammation
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Commission (EC) has expanded the marketing authorization for Dupixent (dupilumab) in the European Union. Dupixent is now also approved in children aged 6 to 11 years as an add-on maintenance treatment for severe asthma with type 2 inflammation characterized by raised blood eosinophils and/or raised ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you